MTOR and Insulin resistance: Because of the prolonged and elevated insulin resistance due to immunosuppressive agents such as steroids, CNIs, and mTOR inhibitors administered for a long time at a late post-transplant stage, long-term compensatory insulin secretion of pancreatic β cells may be required to prevent impaired glucose metabolism in KTRs.